Better mental wellbeing substantially reduces the risk of developing irritable bowel syndrome (IBS), with effects that are independent of genetic predisposition and partly mediated through lower depression and anxiety. In this prospective UK Biobank cohort of 75,842 IBS-free participants followed for 12.4 years, 1,400 incident IBS cases occurred, and higher life satisfaction and positive affect were strongly protective (HRs 0.41 and 0.50), while neuroticism and depressive/anxiety symptoms markedly increased risk (HRs 2.35 and 3.09). These associations were consistent across IBS subtypes, and mediation analyses attributed about 27% of the protective effect of mental wellbeing to reductions in depression and anxiety. Mendelian randomization supported a causal protective role of positive wellbeing, and proteomic profiling linked mental wellbeing–related proteins—particularly chromogranin A and gastrin—to IBS risk, with pathways enriched in cytokine–cytokine receptor signaling. Overall, the findings highlight mental wellbeing as a powerful determinant of IBS risk and underscore psychological health as a promising target for primary prevention. Source: https://journals.lww.com/ajg
A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…
A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…
A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…
A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…
A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…
To address uncertainties in statin safety profiles, which are often based on observational data susceptible…
This website uses cookies.